BRIEF-Sellas Gets Green Light to Continue Phase 3 REGAL Trial of GPS in AML After Positive Data Review

Reuters08-07

Aug 7 (Reuters) - Sellas Life Sciences Group Inc SLS.O:

SELLAS LIFE SCIENCES ANNOUNCES INDEPENDENT DATA MONITORING COMMITTEE PERIODIC REVIEW AND POSITIVE RECOMMENDATION TO CONTINUE PIVOTAL PHASE 3 REGAL TRIAL OF GPS IN AML WITHOUT MODIFICATION
SELLAS LIFE SCIENCES GROUP INC - IDMC FINDS NO SAFETY CONCERNS IN GPS TRIAL
SELLAS LIFE SCIENCES GROUP INC: FINAL ANALYSIS ANTICIPATED BY YEAR-END UPON OCCURRENCE OF 80 EVENTS

Source text: ID:nGNX47xTHB

Further company coverage: SLS.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2557565029?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-07 20:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2557565029","market":"fut","top_or_hot":-1,"title":"BRIEF-Sellas Gets Green Light to Continue Phase 3 REGAL Trial of GPS in AML After Positive Data Review","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Sellas Gets Green Light to Continue Phase 3 REGAL Trial of GPS in AML After Positive Data Review</title></head><body><p><span>Aug 7 (Reuters)</span><span> - </span>Sellas Life Sciences Group Inc <span>SLS.O</span>:</p><ul><li><p>SELLAS LIFE SCIENCES ANNOUNCES INDEPENDENT DATA MONITORING COMMITTEE PERIODIC REVIEW AND POSITIVE RECOMMENDATION TO CONTINUE PIVOTAL PHASE 3 REGAL TRIAL OF GPS IN AML WITHOUT MODIFICATION</p></li><li><p>SELLAS LIFE SCIENCES GROUP INC - IDMC FINDS NO SAFETY CONCERNS IN GPS TRIAL</p></li><li><p>SELLAS LIFE SCIENCES GROUP INC: FINAL ANALYSIS ANTICIPATED BY YEAR-END UPON OCCURRENCE OF 80 EVENTS</p></li></ul><p>Source text: <span>ID:nGNX47xTHB</span></p><p>Further company coverage: <span>SLS.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Sellas Gets Green Light to Continue Phase 3 REGAL Trial of GPS in AML After Positive Data Review</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Sellas Gets Green Light to Continue Phase 3 REGAL Trial of GPS in AML After Positive Data Review\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-08-07 20:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Sellas Gets Green Light to Continue Phase 3 REGAL Trial of GPS in AML After Positive Data Review</title></head><body><p><span>Aug 7 (Reuters)</span><span> - </span>Sellas Life Sciences Group Inc <span>SLS.O</span>:</p><ul><li><p>SELLAS LIFE SCIENCES ANNOUNCES INDEPENDENT DATA MONITORING COMMITTEE PERIODIC REVIEW AND POSITIVE RECOMMENDATION TO CONTINUE PIVOTAL PHASE 3 REGAL TRIAL OF GPS IN AML WITHOUT MODIFICATION</p></li><li><p>SELLAS LIFE SCIENCES GROUP INC - IDMC FINDS NO SAFETY CONCERNS IN GPS TRIAL</p></li><li><p>SELLAS LIFE SCIENCES GROUP INC: FINAL ANALYSIS ANTICIPATED BY YEAR-END UPON OCCURRENCE OF 80 EVENTS</p></li></ul><p>Source text: <span>ID:nGNX47xTHB</span></p><p>Further company coverage: <span>SLS.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SLS","symbol_name":"SELLAS Life Sciences Group Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nTUA40R9DW:1","article_id":"2557565029","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2557565029","pubTimestamp":1754571060,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Sellas Gets Green Light to Continue Phase 3 REGAL Trial of GPS in AML After Positive Data ReviewAug 7 (Reuters) - Sellas Life Sciences Group Inc SLS.O:SELLAS LIFE SCIENCES ANNOUNCES INDEPENDENT ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SLS":"SELLAS Life Sciences Group Inc.","BK4139":"生物科技"},"translate_title":"简介-经过积极的数据审查后，Sellas获准继续进行GPS治疗AML的3期REGAL试验","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SLS":0.9},"content_text":"BRIEF-Sellas Gets Green Light to Continue Phase 3 REGAL Trial of GPS in AML After Positive Data ReviewAug 7 (Reuters) - Sellas Life Sciences Group Inc SLS.O:SELLAS LIFE SCIENCES ANNOUNCES INDEPENDENT DATA MONITORING COMMITTEE PERIODIC REVIEW AND POSITIVE RECOMMENDATION TO CONTINUE PIVOTAL PHASE 3 REGAL TRIAL OF GPS IN AML WITHOUT MODIFICATIONSELLAS LIFE SCIENCES GROUP INC - IDMC FINDS NO SAFETY CONCERNS IN GPS TRIALSELLAS LIFE SCIENCES GROUP INC: FINAL ANALYSIS ANTICIPATED BY YEAR-END UPON OCCURRENCE OF 80 EVENTSSource text: ID:nGNX47xTHBFurther company coverage: SLS.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2557565029","isCrawlerRequest":true}